T
TriSalus Life Sciences Inc
NASDAQ:TLSI
TriSalus Life Sciences Inc
NASDAQ:TLSI
Price:
4.89
USD
-2.2%
Market Closed
Market Cap:
$244.3m
Balance Sheet
Balance Sheet Decomposition
TriSalus Life Sciences Inc
TriSalus Life Sciences Inc
Balance Sheet Decomposition is not available for
TriSalus Life Sciences Inc
TriSalus Life Sciences Inc
Balance Sheet
TriSalus Life Sciences Inc
TriSalus Life Sciences Inc
Currency: USD
| Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|
| Assets | ||||||
| Cash & Cash Equivalents |
1
|
0
|
0
|
12
|
9
|
|
| Cash |
1
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
0
|
0
|
12
|
9
|
|
| Total Receivables |
0
|
0
|
0
|
4
|
5
|
|
| Accounts Receivables |
0
|
0
|
0
|
4
|
5
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
3
|
4
|
|
| Other Current Assets |
1
|
0
|
0
|
6
|
6
|
|
| Total Current Assets |
2
|
1
|
0
|
21
|
21
|
|
| PP&E Net |
0
|
0
|
0
|
3
|
3
|
|
| PP&E Gross |
0
|
0
|
0
|
3
|
3
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
3
|
4
|
|
| Intangible Assets |
0
|
0
|
0
|
1
|
0
|
|
| Other Long-Term Assets |
250
|
250
|
20
|
0
|
0
|
|
| Total Assets |
252
N/A
|
251
-1%
|
20
-92%
|
25
+22%
|
24
-3%
|
|
| Liabilities | ||||||
| Accounts Payable |
0
|
1
|
1
|
3
|
2
|
|
| Accrued Liabilities |
0
|
0
|
0
|
11
|
7
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
1
|
1
|
0
|
0
|
|
| Total Current Liabilities |
0
|
2
|
3
|
15
|
10
|
|
| Long-Term Debt |
0
|
0
|
1
|
0
|
22
|
|
| Other Liabilities |
23
|
16
|
10
|
37
|
18
|
|
| Total Liabilities |
24
N/A
|
17
-26%
|
14
-21%
|
52
+277%
|
50
-3%
|
|
| Equity | ||||||
| Common Stock |
224
|
250
|
20
|
0
|
0
|
|
| Retained Earnings |
1
|
17
|
13
|
250
|
280
|
|
| Additional Paid In Capital |
6
|
0
|
0
|
222
|
254
|
|
| Total Equity |
229
N/A
|
233
+2%
|
7
-97%
|
27
N/A
|
26
+4%
|
|
| Total Liabilities & Equity |
252
N/A
|
251
-1%
|
20
-92%
|
25
+22%
|
24
-3%
|
|
| Shares Outstanding | ||||||
| Common Shares Outstanding |
31
|
31
|
8
|
26
|
31
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
4
|
4
|
|
Switch to:
Switch to:
See Also
Discover More
